Judo Bio

Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of oligonucleotide therapies intended to offer genetic medicines. Judo Bio is based in Cambridge, MA and was founded in 2021. Its last known valuation is $115 million. It has raised $105 million across 3 recorded rounds; the latest was a $25 million early-stage round in Jul 2024.

Last price · $/share
—
Implied valuation
$115.0M
Total raised
$105.0M
Last round
Early Stage VC
Jul 2024
How much has Judo Bio raised?
$105.0Macross 3 recorded rounds · Nov 2022 – Jul 2024

Most recently, Judo Bio raised $25.0M in its Early Stage VC (Jul 2024).

Free account
More of Judo Bio with a free account
  • ·Watch Judo Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Judo Bio round by round

3 rounds
Jul 2024Early Stage VC$25.0MSEC filing▮
21 investors participated
May 2024Early Stage VC$5.0MSEC filing▮
2 investors participated
Nov 2022Early Stage VC$25.0MSEC filing▮
2 investors participated

How much has Judo Bio raised?

Judo Bio has raised $105 million across 3 recorded rounds since 2022. The largest was a $5 million early-stage round in May 2024; the most recent was a $25 million early-stage round in Jul 2024.

Judo Bio has filed 4 Form Ds with the SEC since 2022, most recently in Aug 2024 ($25 million sold to 21 investors).

Judo Bio investors

7 investors are on record for Judo Bio, including Alexandria Venture Investments, Digitalis Ventures, Euclidean Capital and Atlas Venture. The early-stage round in Jul 2024 drew 21 investors.

For fundraisers
Raising for a company like Judo Bio?

7 investors have backed Judo Bio.

See all 7 investors →

Frequently asked about Judo Bio

How much has Judo Bio raised?
Judo Bio has raised $105.0M in total across 3 recorded funding rounds.
When was Judo Bio's last funding round?
Judo Bio's most recent recorded round was Early Stage VC in Jul 2024, raising $25.0M.